GW Pharma's Price Target Raised To $208 At Cantor By: Benzinga via Benzinga December 05, 2016 at 14:24 PM EST Cantor Fitzgerald has raised its price target on GW Pharmaceuticals PLC-ADR (NASDAQ: GWPH) to $208/ADS from $182/ADS after additional ... Read More >> Related Stocks: AES Corp Gw Pharma ADR